Biocon said on Thursday it has inked an exclusive pact with US-based Mylan to develop and commercialise generic versions of its three insulin products.The Bengaluru-based firm has entered into a......
Wockhardt, the Mumbai-based leading pharmaceutical and biotechnology company that is struggling to repay its nearly Rs 900-crore (Rs 9 billion) debt, is paying the price for its aggressive......
A vast, unwieldy population, a plethora of diseases, and rampant poverty: this was the picture India presented to the outside world till a while ago.But these days the fact that India has the......